2-phenylglutaric anhydride,
2-Phenylglutaric anhydride,
2959-96-8,
3-Phenyldihydro-2H-pyran-2,6(3H)-dione,
2H-Pyran-2,6(3H)-dione, dihydro-3-phenyl-,
.alpha.-Phenylglutaric anhydride,
NVPRNSAYSSEIGR-UHFFFAOYSA-N,
EINECS 220-991-5,
3-phenyl-tetrahydro-pyran-2,6-dione,
2-Phenylglutaric anhydride treated BSA,
2-Phenylglutaricanhydride,
AC1Q6EJC,
AC1Q6MFP,
3-phenyloxane-2,6-dione,
NCIOpen2_000311,
SCHEMBL192372,
AC1L3W58,
CTK4G3539,
2-Phenylglutaric anhydride, 95%,
3-Phenyl-dihydro-pyran-2,6-dione,
NSC65629,
MFCD00006681,
NSC-65629,
AKOS004115286,
AKOS016844124,
FCH1117838,
CC-11833,
dihydro-3-phenyl-2H-pyran-2,6(3H)dione,
AX8078190,
DB-047612,
FT-0613335,
Z2600,
2H-Pyran-2,6(3H)-dione,dihydro-3-phenyl-,
3-Phenyldihydro-2H-pyran-2,6(3H)-dione #,
C-30761,
S01-0489,
2-Phenylglutaric anhydride treated bovine serum albumin,
C11H10O3,
CID96293,
AR-1F5029,
C11-H10-O3,
30413-69-5,
DTHKSEIAHRFKDLGEEQFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHPYFYAPELLYYANKYNGVFQDCCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEVEKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCTKPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA,